The power of a unique process.

An allograft fusion solution with a wide array of endogenous growth factors.

Clinical Publications

Allogeneic morphogenetic protein vs. recombinant human bone morphogenic protein-2 in lumbar interbody fusion procedures: or radiographic and econimic analysis

Download Clinical Study ›

Clinical Evaluation of Allogeneic Growth Factor in Cervical Spine Fusion

Download Clinical Study ›

Clinical Validation of Allogeneic Morphogenic Protein: Donor Intervariability: Terminal irradiation and Age of Product is not Clinically Relevant

Download Clinical Study ›

Request More Information

To request more information on OSTEOAMP or to contact your local Bioventus Surgical representative to order, please fill out this form.

Instructions for Use:
OSTEOAMP – DCI Doner Services Tissue Bank
OSTEOAMP – Lifelink Tissue Bank
OSTEOAMP – Pinnacle Transplant Technologies

Material Management Packet:
OSTEOMAP Material Management Packet

First Name*

Last Name*


Phone Number*


Job Title*

Your Question or Comment*

Subject of Inquiry*

*Fields with asterisks are mandatory

  1. Data on file. RPT-000327 Report of Growth Factor Concentrations in Bone and Bone Marrow Aspirate, December 3, 2010, Advanced Biologics, LLC. Data from a single lot of OSTEOAMP sponge product.

  2. Data on file. TR1005 Growth Factor Concentrations in Sponges, Granules and Putty, July 5, 2011, Advanced Biologics, LLC.

  3. Roh JS, Yeung CA, Field JS, McClellan RT. Allogeneic morphogenetic protein vs. recombinant human bone morphogenetic protein-2 in lumbar interbody fusion rocedures: a radiographic and economic analysis. J Orthop Surg Res, 2013, 8:49 doi:10.1186/1749-799X-8-49.

  4. Bae H, Zhao L, Zhu D, Kanim L, Wang J, Delamarter R. Variability Across Ten Production Lots of a Single Demineralized Bone Matrix Product. J Bone Joint Surg Am. 2010; 92:427-435.